Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer (Q43990453)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer |
scientific article |
Statements
1 reference
Phase II multicenter study of docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer (English)
1 reference
Lee S Schwartzberg
1 reference
Suprith Badarinath
1 reference
Mark R Keaton
1 reference
Barrett H Childs
1 reference
27 December 2013
1 reference
1 reference
Identifiers
1 reference